How Anaplastic Large Cell Lymphoma Is Diagnosed

Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma that affects white blood cells called lymphocytes. Diagnosing ALCL involves a series of tests, including a physical exam, imaging scans, and most importantly, a biopsy. A biopsy allows doctors to examine tissue samples under a microscope and perform special tests to confirm the presence and specific type of ALCL.

What is Anaplastic Large Cell Lymphoma?

Anaplastic large cell lymphoma (ALCL) is a rare cancer of the immune system, specifically a type of non-Hodgkin lymphoma. It develops when certain white blood cells, called T-lymphocytes or, less commonly, natural killer (NK) cells, grow abnormally. These abnormal cells, known as anaplastic cells, often have a distinct appearance and express a protein called CD30, which helps in diagnosis.

ALCL is characterized by large, abnormal immune cells that can be found in lymph nodes, skin, bone, and other organs. There are different forms of ALCL. Systemic ALCL affects the body's lymphatic system and can be further classified as ALK-positive or ALK-negative, depending on the presence of a specific genetic change (anaplastic lymphoma kinase, or ALK protein). Another distinct type is breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). This rare form develops in the fluid or scar tissue around breast implants, typically textured implants, rather than in the breast tissue itself. While BIA-ALCL is a type of cancer, it is often curable, especially when detected early. Understanding the specific type of ALCL is crucial because it influences the treatment plan and outlook. Your doctor will use various tests to determine which type of ALCL you may have.

Symptoms

The symptoms of anaplastic large cell lymphoma (ALCL) can vary widely depending on where the cancer is located in the body. Common symptoms often include swollen, painless lymph nodes, which are small, bean-shaped glands that are part of your immune system. Other general symptoms, sometimes called B symptoms, may also be present, indicating the body's systemic response to the lymphoma.

For systemic ALCL, common signs include swollen lymph nodes in the neck, armpit, or groin. You might also experience B symptoms, which are a group of general symptoms that can occur with many lymphomas. These include unexplained fever, drenching night sweats, and unexplained weight loss (losing 10% or more of your body weight over six months). Other symptoms can arise depending on where the lymphoma cells accumulate. For example, if the lymphoma affects the skin, you might notice skin rashes or lumps. Bone pain could occur if the bones are involved, and breathing problems might develop if the lungs are affected. These symptoms are not unique to ALCL and can be caused by many other less serious conditions. Breast implant-associated ALCL (BIA-ALCL) has specific symptoms related to the breast implant. The most common sign is a sudden swelling of the breast due to fluid buildup (seroma) around the implant. You might also feel a lump in the breast or armpit, or experience pain, redness, or a rash on the breast. It's important to note that these symptoms can also be caused by other conditions, so medical evaluation is necessary.

Causes & risk factors

The exact cause of anaplastic large cell lymphoma (ALCL) is often unknown, and in most cases, it develops without a clear reason. However, certain factors are associated with an increased risk for specific types of ALCL. These factors are not direct causes but rather elements that may make someone more likely to develop the condition, though many people with these risk factors never get ALCL.

For systemic ALCL, the cause is generally not understood. It is not contagious and cannot be passed from person to person. Researchers are studying genetic changes and immune system factors that might play a role. For instance, the presence of the ALK protein (ALK-positive ALCL) is due to a specific genetic rearrangement in the lymphoma cells themselves, which drives their growth. Breast implant-associated ALCL (BIA-ALCL) is linked to breast implants, particularly those with textured surfaces. While the exact mechanism is still being researched, it is thought that chronic inflammation around the implant, possibly due to bacterial contamination or a reaction to the implant surface, may contribute to its development. It's important to understand that BIA-ALCL is very rare, affecting only a small number of people with textured implants. Other general risk factors for non-Hodgkin lymphoma, which might indirectly apply to ALCL, include certain immune system deficiencies or autoimmune diseases, and exposure to some viruses like human T-lymphotropic virus type 1 (HTLV-1), though this is less commonly associated with ALCL specifically. Most people who develop ALCL do not have any identifiable risk factors.

How it's diagnosed

Diagnosing anaplastic large cell lymphoma (ALCL) involves a thorough medical evaluation, including a physical exam and a review of your medical history. The most critical step is a biopsy, where a small tissue sample is removed and examined. This sample undergoes specialized laboratory tests to confirm the presence of ALCL and determine its specific type, guiding subsequent treatment decisions.

If ALCL is suspected, your doctor will first conduct a physical exam to check for swollen lymph nodes or other lumps. They will also ask about your symptoms and medical history. However, a definitive diagnosis always requires a biopsy. During a biopsy, a surgeon removes a small piece of suspicious tissue, such as a swollen lymph node, a skin lesion, or fluid around a breast implant. Once the tissue is collected, it is sent to a pathologist, a doctor who specializes in diagnosing diseases by examining tissues and cells. The pathologist will look at the cells under a microscope to identify the characteristic large, abnormal cells of ALCL. They will also perform special tests on the tissue, such as immunohistochemistry, to check for specific proteins like CD30 and the ALK protein. These markers are crucial for confirming ALCL and classifying it as ALK-positive or ALK-negative systemic ALCL, or BIA-ALCL. After ALCL is confirmed, further tests are done to determine the extent of the disease (staging). These may include imaging tests like computed tomography (CT) scans, positron emission tomography (PET) scans, or magnetic resonance imaging (MRI) scans. These scans help doctors see if the lymphoma has spread to other parts of the body. A bone marrow biopsy, where a small sample of bone marrow is taken, may also be performed to check for lymphoma cells in the bone marrow. Blood tests are also done to assess overall health and organ function. For BIA-ALCL, an ultrasound or MRI of the breast is often used to visualize fluid around the implant.

Treatment options

Treatment for anaplastic large cell lymphoma (ALCL) depends on the specific type of ALCL, its stage, and your overall health. The primary goal of treatment is to eliminate the cancer cells and achieve remission. Common treatment approaches include chemotherapy, targeted therapy, and sometimes radiation therapy or surgery, especially for breast implant-associated ALCL.

For systemic ALCL, chemotherapy is usually the first line of treatment. This involves using powerful drugs to kill cancer cells throughout the body. The specific chemotherapy regimen will depend on whether the ALCL is ALK-positive or ALK-negative. ALK-positive ALCL often responds very well to standard chemotherapy. Targeted therapies, such as brentuximab vedotin, which specifically targets the CD30 protein found on ALCL cells, may also be used, especially for relapsed or refractory (not responding to initial treatment) disease, or in combination with chemotherapy. Radiation therapy, which uses high-energy rays to kill cancer cells, may be used in specific situations, such as to treat localized areas of lymphoma or to relieve symptoms. In some cases, a stem cell transplant (also known as a bone marrow transplant) may be considered, particularly for patients whose ALCL has returned after initial treatment. This involves replacing diseased bone marrow with healthy stem cells. For breast implant-associated ALCL (BIA-ALCL), the primary treatment is often surgery to remove the breast implant and the surrounding capsule (the scar tissue that forms around the implant). This procedure, called capsulectomy with implant removal, is often curative if the disease is confined to the capsule. In cases where the BIA-ALCL has spread beyond the capsule, additional treatments like chemotherapy or radiation therapy may be necessary. Your medical team will develop a personalized treatment plan based on your unique situation.

Recovery & outlook

The recovery and outlook for anaplastic large cell lymphoma (ALCL) vary significantly depending on the specific type of ALCL and how it responds to treatment. Many people with ALCL achieve remission, meaning the signs and symptoms of cancer disappear. Regular follow-up appointments are crucial after treatment to monitor for any signs of recurrence and manage potential long-term side effects.

For systemic ALCL, the outlook is generally more favorable for ALK-positive cases compared to ALK-negative cases. ALK-positive ALCL often responds very well to chemotherapy, and many patients achieve long-term remission. ALK-negative ALCL can be more challenging to treat and may have a higher risk of recurrence, but newer targeted therapies are improving outcomes. Breast implant-associated ALCL (BIA-ALCL) typically has an excellent prognosis, especially when diagnosed early and treated with complete surgical removal of the implant and capsule. The vast majority of BIA-ALCL cases are cured with surgery alone. However, if the disease has spread, the outlook can be more complex, requiring additional treatments. After treatment, you will need regular follow-up care, which may include physical exams, blood tests, and imaging scans. This monitoring helps detect any signs of the lymphoma returning early. It's important to discuss any new or worsening symptoms with your doctor. Recovery also involves managing potential side effects from treatment, which can sometimes be long-lasting. Your healthcare team will provide support and guidance throughout your recovery journey.

When to see a doctor

You should see a doctor if you experience any persistent or concerning symptoms that could indicate anaplastic large cell lymphoma (ALCL). While many symptoms are common to less serious conditions, it's important to get them checked, especially if they are new, worsening, or don't go away. Early diagnosis can lead to more effective treatment and better outcomes.

Make an appointment with your doctor if you notice any of the following: * **Persistent swollen lymph nodes:** If you have swollen glands in your neck, armpit, or groin that don't go down after a few weeks, or if they continue to grow. * **Unexplained fever:** Fevers that occur without an obvious infection and last for several days or weeks. * **Drenching night sweats:** Sweats so severe that they soak your clothes or bedding, even in a cool room. * **Unexplained weight loss:** Losing a significant amount of weight (e.g., more than 10% of your body weight) over a short period without trying. * **New lumps or rashes:** Any unusual lumps on your skin or persistent skin rashes that don't resolve. If you have breast implants, especially textured ones, and notice any changes around your breast, such as sudden swelling, a new lump, pain, or a rash, you should see your doctor promptly. While these symptoms can be caused by other conditions, it's essential to rule out breast implant-associated ALCL. Always discuss your concerns with a qualified healthcare professional, as they can provide an accurate diagnosis and appropriate guidance.

Frequently asked questions

Is Anaplastic Large Cell Lymphoma (ALCL) a common cancer?

No, ALCL is considered a rare type of non-Hodgkin lymphoma. It accounts for a small percentage of all lymphomas, making it less common than many other cancers. However, awareness and accurate diagnosis are still very important.

Can ALCL be cured?

Yes, many cases of ALCL can be cured, especially ALK-positive systemic ALCL and breast implant-associated ALCL (BIA-ALCL) when diagnosed early. The specific outlook depends on the type of ALCL, how advanced it is, and how well it responds to treatment.

What is the difference between ALK-positive and ALK-negative ALCL?

The difference lies in the presence of a specific genetic change that leads to the production of the ALK protein. ALK-positive ALCL has this protein, often responds better to standard chemotherapy, and generally has a more favorable outlook. ALK-negative ALCL lacks this protein and can sometimes be more challenging to treat.

Are all breast implants linked to BIA-ALCL?

No, BIA-ALCL is primarily associated with textured breast implants, not smooth implants. Even with textured implants, BIA-ALCL is very rare. If you have breast implants and concerns, discuss them with your plastic surgeon or doctor.

What is the most important test for diagnosing ALCL?

The most important test for diagnosing ALCL is a biopsy. This procedure involves taking a small tissue sample from a suspicious area, such as a swollen lymph node or fluid around an implant. Pathologists then examine this sample under a microscope and perform special tests to confirm ALCL.

What happens after ALCL treatment?

After ALCL treatment, you will typically have regular follow-up appointments with your doctor. These appointments involve physical exams, blood tests, and sometimes imaging scans to monitor your health, check for any signs of the lymphoma returning, and manage any long-term side effects from treatment.

Sources

• MedlinePlus — How Anaplastic Large Cell Lymphoma Is Diagnosed
• Mayo Clinic — How Anaplastic Large Cell Lymphoma Is Diagnosed
• Cochrane Library — How Anaplastic Large Cell Lymphoma Is Diagnosed